That is when they were actually diluting. If they were diluting now, we would see the same kind of price decline. Will they recover? I dunno. The things they have in the pipeline have enough value to get them back up there but it will be all about investor confidence IMO. And right now there isnt a whole lot of that. Nonetheless, still undervalued at this point.
It climbed up over 3000% on the PR of Neuromancer deal and that fact that it would have a budget $60 million+. You can't expect a stock to stay up on just a PR. So inevitably it fell. If you were smart, you would have sold on that news.
What will make the stock stay above a $1 is when the revenue from deals starts coming through and showing itself on their Quarterly filings.